Biomarin Pharmaceutical reported $-9158000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Bayer BAYN:GR € 2089M 946M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Gilead Sciences GILD:US $ 4370M 1605M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Insmed INSM:US $ -91545000 6.9M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Moderna Inc MRNA:US 3.63B 497M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
United Therapeutics UTHR:US $ 242.3M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M